Yuko Sasaki
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuko Sasaki.
Molecular and Cellular Biochemistry | 2006
Osamu Ito; Yasuhiro Nakamura; Liping Tan; Tsuneo Ishizuka; Yuko Sasaki; Naoyoshi Minami; Masayuki Kanazawa; Sadayoshi Ito; Hironobu Sasano; Masahiro Kohzuki
Members of the cytochrome P-450 4 (CYP4) family catalyze the ω-hydroxylation of fatty acids, and some of them have the PPAR response element in the promoter area of the genes. The localization of CYP4A and PPAR isoforms and the effect of PPAR agonists on CYP4A protein level and activity were determined in rat kidney and liver. Immunoblot analysis showed that CYP4A was expressed in the liver and proximal tubule, with lower expression in the preglomerular microvessel, glomerulus and thick ascending limb (TAL), but the expression was not detected in the collecting duct. PPARα was expressed in the liver, proximal tubule and TAL. PPARγ was expressed in the collecting duct, with lower expression in the TAL, but no expression in the proximal tubule and liver. The PPARα agonist clofibrate induced CYP4A protein levels and activity in the renal cortex and liver. The PPARγ agonist pioglitazone did not modulate them in these tissues. The localization of CYP4A and CYP4F were further determined in human kidney and liver by immunohistochemical technique. Immunostainings for CYP4A and CYP4F were observed in the hepatocytes of the liver lobule and the proximal tubules, with lower stainings in the TALs and collecting ducts, but no staining in the glomeruli or renal vasculatures. These results indicate that the inducibility of CYP4A by PPAR agonists in the rat tissues correlates with the expression of the respective PPAR isoforms, and that the localization of CYP4 in the kidney has a species-difference between rat and human.
Journal of Neurogenetics | 2012
Ryota Adachi; Yuko Sasaki; Hiromi Morita; Michio Komai; Hitoshi Shirakawa; Tomoko Goto; Akira Furuyama; Kunio Isono
Abstract: Transgenic Drosophila expressing human T2R4 and T2R38 bitter-taste receptors or PKD2L1 sour-taste receptor in the fly gustatory receptor neurons and other tissues were prepared using conventional Gal4/UAS binary system. Molecular analysis showed that the transgene mRNAs are expressed according to the tissue specificity of the Gal4 drivers. Transformants expressing the transgene taste receptors in the fly taste neurons were then studied by a behavioral assay to analyze whether transgene chemoreceptors are functional and coupled to the cell response. Since wild-type flies show strong aversion against the T2R ligands as in mammals, the authors analyzed the transformants where the transgenes are expressed in the fly sugar receptor neurons so that they promote feeding ligand-dependently if they are functional and activate the neurons. Although the feeding preference varied considerably among different strains and individuals, statistical analysis using large numbers of transformants indicated that transformants expressing T2R4 showed a small but significant increase in the preference for denatonium and quinine, the T2R4 ligands, as compared to the control flies, whereas transformants expressing T2R38 did not. Similarly, transformants expressing T2R38 and PKD2L1 also showed a similar preference increase for T2R38-specific ligand phenylthiocarbamide (PTC) and a sour-taste ligand, citric acid, respectively. Taken together, the transformants expressing mammalian taste receptors showed a small but significant increase in the feeding preference that is taste receptor and also ligand dependent. Although future improvements are required to attain performance comparable to the endogenous robust response, Drosophila taste neurons may serve as a potential in vivo heterologous expression system for analyzing chemoreceptor function.
American Journal of Hypertension | 2006
Masayuki Kanazawa; Takayuki Kawamura; Lan Li; Yuko Sasaki; Kayomi Matsumoto; Hitomi Kataoka; Osamu Ito; Naoyoshi Minami; Toshinobu Sato; Tetsuya Ootaka; Masahiro Kohzuki
Journal of Hypertension | 2008
Andreia Tufescu; Masayuki Kanazawa; Atsuko Ishida; Hongmei Lu; Yuko Sasaki; Tetsuya Ootaka; Toshinobu Sato; Masahiro Kohzuki
American Journal of Hypertension | 2009
Hongmei Lu; Masayuki Kanazawa; Atsuko Ishida; Andreia Tufescu; Yuko Sasaki; Osamu Ito; Hajime Kurosawa; Toshinobu Sato; Tetsuya Ootaka; Masahiro Kohzuki
Plasma and Fusion Research | 2016
Yuko Sasaki; Sho Takayama; Haruhisa Nakano; Atsushi Komuro; Kazunori Takahashi; Akira Ando
Nippon Jibiinkoka Gakkai Kaiho | 2018
Manabu Mogitate; Yuko Sasaki; Ayako Komiyama
Archive | 2006
Yoko Goto; Masahiro Kohzuki; Yuko Sasaki; Hajime Kurosawa; Tokutaro Sato
Japanese Journal of Nephrology | 2006
Yuko Sasaki; Masayuki Kanazawa; Osamu Ito; Masahiro Kohzuki
Journal of Hypertension | 2004
Masayuki Kanazawa; L. Li; K. Matsumoto; Yuko Sasaki; H. Li; Takayuki Kawamura; Naoyoshi Minami; Hajime Kurosawa; T. Harada; Nobuyoshi Mori; Makoto Nagasaka; Osamu Ito; Masahiro Kohzuki